Journal of Clinical Trials
Open Access
ISSN: 2167-0870
ISSN: 2167-0870
Department of Immunology and Immunotherapy, Zhengzhou University, Zhengzhou, China
Research Article
Treatment Burden for Older People with Multimorbidity: A Cross-Sectional Study in China
Author(s): Liyuan Dou*
Background: There has been little research in China about treatment burden. Studies internationally have found
high treatment burden is associated with number of long-term conditions, low Quality of Life (QoL) and poor
medication adherence. The purpose of this study is to understand factors associated with high treatment burden for
older people with multimorbidity in China.
Methods: Cross-sectional survey was conducted from February to May 2022. Through convenience sampling, 353
older people (≥ 60 years) with multimorbidity (≥ 2 long term conditions) admitted to hospital in Zhengzhou, China,
were invited to complete a survey including sociodemographic characteristics, long-term conditions and the Chinese
version of Multimorbidity Treatment Burden Questionnaire (C-MTBQ). Ordinal logistic regression was used to
identif.. View More»
DOI:
10.35248/2167-0870.23.13.518